Thanks Trding, Excellent poster. From the co
Post# of 145770
Excellent poster.
From the conclusions:
Quote:
In the HTE subjects with MDR virus, the CCR5-tropic strains were susceptible to PRO 140 and they were not significantly influenced by MVC exposure.
While a substantial proportion of HTE subjects may harbor X4 or D/M viruses, PRO 140 can play a key role in subjects with very limited therapeutic options and CCR5-tropic virus.
This is for VERY tough 4-class drug-resistant HIV sufferers. Out Lero seems to be able to help and the fact that they where using Maraviroc did not affect the activity of Leronlimab.
Great news form any perspective !!!
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)